- Skeptical Antares investors have been selling the stock.
- Conservative OTREXUP estimates provide attractive risk/reward.
- Most of the downside has been discounted from the current stock price.
Antares Pharma, Inc., is a specialty pharmaceutical company developing and commercializing self-administered parenteral pharmaceutical products and technologies and topical gel-based products. Its products include OTREXUP and Medi-Jet.
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.